title: Clozapine in China: a review and preview of US/PRC collaboration.
authors.affiliation: Department of Health and Human Services, National Institute of Mental Health, Bethesda, MD 20892.
authors.forename: W Z
authors.initials: WZ
authors.lastname: Potter
authors.forename: G N
authors.initials: GN
authors.lastname: Ko
authors.forename: L D
authors.initials: LD
authors.lastname: Zhang
authors.forename: W W
authors.initials: WW
authors.lastname: Yan
mesh_terms: D000328:Adult; D002681:China; D002746:Chlorpromazine / Q000627:therapeutic use; D003024:Clozapine / Q000009:adverse effects / Q000627:therapeutic use*; D003984:Dibenzazepines / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006719:Homovanillic Acid / Q000097:blood; D006801:Humans; D007391:International Cooperation; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D016032:Randomized Controlled Trials as Topic; D012559:Schizophrenia / Q000188:drug therapy*; D014481:United States
chemical_list: D003984:Dibenzazepines; D003024:Clozapine; D002746:Chlorpromazine; D006719:Homovanillic Acid